About QX THERAPEUTICS, INC.
Qx Therapeutics Inc., founded in 2017, is a Delaware corporation operating in Connecticut, US. The company focuses on drug research and development for innovative treatments targeting unmet medical needs in acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS).
Drug research and developmentTreatment of acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS)Development of QXT-101, a first-in-class treatment for ALI patientsFDA authorization for clinical trials, including Phase 2 trials for QXT-101
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to QX THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.